JIA, Yong,KASIBHATLA, Shailaja,BILIC, Sanela,CAMERON, John,HOWARD, JR., Danny
申请号：
HK18107449
公开号：
HK1247850A1
申请日:
2018.06.07
申请国别(地区):
HK
年份:
2018
代理人:
摘要：
The present invention relates to a pharmaceutical composition comprising PD-1 antagonist and an EGFR Inhibitor. The present combination can be administered independently or separately, in a quantity which is jointly therapeutically effective for the treatment of cancer. The invention also provides the use of such a combination for the manufacture of a medicament； the use of such a combination as a medicine； a kit of part comprising such a combination； and a method of treatment of such a combination.
